GAMCO Investors’s Amicus Therapeutics FOLD Stock Holding History

GAMCO Investors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,000	Closed	-$578K	–	972
2026 Q1	$578K	Buy	+40,000	New	+$573K	0.01%	740

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

GAMCO Investors's FOLD Position: Q2 2026 in Review

GAMCO Investors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 40,000 shares — an estimated $578K sold.

GAMCO Investors first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $578K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

GAMCO Investors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
GAMCO Investors sold 40,000 Amicus Therapeutics shares in Q2 2026, an estimated $578K.
GAMCO Investors first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
GAMCO Investors's Amicus Therapeutics position peaked at $578K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.